Core Insights - The company has made significant progress in the commercialization of AI large models and intelligent agents, covering various sectors including marketing, healthcare, pharmacies, and consumer management, thereby reaching a comprehensive health industry cooperation network [1] Group 1: Marketing - The company has launched the "AI Marketing Laboratory" and introduced the "Tiangong No.1 Commercial Intelligent Agent," providing "+AI" digital solutions to 182 pharmaceutical companies, enabling rapid response and efficient decision-making in a changing environment [1] Group 2: Healthcare - Utilizing its self-developed "Zhuo Mu Niao Medical Large Model," the company has introduced the intelligent agent "iMDT" for multidisciplinary joint consultations, serving 512 hospitals and empowering over 1,520 clinical doctors in complex medical diagnoses, significantly improving the decision quality of multidisciplinary teams (MDT) [1] Group 3: Pharmacy - The company has launched an intelligent agent for pharmacies, serving over 10,993 pharmacies, and established a matrix of five AI intelligent agents covering operational insights, products, diseases, members, and employees, as well as specialized AI for "individuals, families, diseases, and medications" to empower store operations [1] Group 4: Health Management - The company has created an AI intelligent agent matrix covering "individuals, families, diseases, and medications," accurately reaching over 3 million users, providing personalized health interventions and risk warnings, and constructing a comprehensive management system that includes prevention, screening, and intervention [1] Group 5: Business Transformation - The company has successfully transformed from a data technology service provider to an AI technology service provider, and will continue to optimize its capabilities in "data + models + scenarios + ecosystem" to become the preferred AI service provider in the health industry [2]

Core Insights - The company has made significant progress in the commercialization of AI large models and intelligent agents, covering various sectors in the health industry, including marketing, healthcare, pharmacies, and consumer management [1][2] Group 1: Marketing - The company has launched the "AI Marketing Laboratory" and introduced the "Tian Gong No. 1 Commercial Intelligent Agent," providing "+AI" digital solutions to 182 pharmaceutical companies, enabling rapid response and efficient decision-making in a changing environment [1] Group 2: Healthcare - Utilizing its self-developed "Zhuo Mu Niao Medical Large Model," the company has introduced the intelligent agent "iMDT" for multidisciplinary joint consultations, serving 512 hospitals and empowering over 1,520 clinical doctors in complex medical diagnoses, significantly improving the decision quality of multidisciplinary teams (MDT) [1] Group 3: Pharmacy - The company has launched an intelligent agent for pharmacies, serving over 10,993 pharmacies, and established a matrix of five AI intelligent agents covering operational insights, products, diseases, memberships, and employees, as well as specialized AI for "individuals, families, diseases, and medications" to enhance store operations [1] Group 4: Health Management - The company has created a matrix of AI intelligent agents covering "individuals, families, diseases, and medications," accurately reaching over 3 million users, providing personalized health interventions and risk warnings, and constructing a comprehensive management system that includes prevention, screening, and intervention [1] Group 5: Business Transformation - The company has successfully transformed from a data technology service provider to an AI technology service provider, continuously optimizing its capabilities in "data + models + scenarios + ecosystem" to become the preferred AI service provider in the health industry [2]

Core Insights - Zhongkang Holdings (02361.HK) has made significant progress in the commercialization of AI large models and intelligent agents, covering various sectors including marketing, healthcare, pharmacies, and consumer management [1] Marketing - The company has launched the "AI Marketing Laboratory" and introduced the "Tiangong No. 1 · Commercial Intelligent Agent," providing "+AI" digital solutions to 182 pharmaceutical companies, enabling rapid response and efficient decision-making in a changing environment [1] Healthcare - In the healthcare sector, the company has developed the "Zhuomuniao Medical Large Model" and launched the intelligent agent "iMDT" for multidisciplinary joint consultations, serving 512 hospitals and empowering over 1,520 clinical doctors to enhance the quality of decision-making in complex medical diagnoses [2] Pharmacies - In the pharmacy sector, the company has introduced an intelligent agent that has served over 10,993 pharmacies, utilizing comprehensive industry data to establish a matrix of five AI intelligent agents covering operational insights, products, diseases, members, and employees, as well as specialized AI for "individuals, families, diseases, and medications" to empower store operations [3] Consumer Management - In health management, the company has created a matrix of AI intelligent agents covering "individuals, families, diseases, and medications," accurately reaching over 3 million users, providing personalized health interventions and risk warnings, and constructing a comprehensive management system that includes prevention, screening, and intervention [4]